MIGENIX Reports Second Quarter Fiscal Year 2008 Financi... ( VANCOUVER and SAN DIEGO Dec. 13 /...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results

Date:12/13/2007

VANCOUVER and SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, reports financial results for the three months ended October 31, 2007 and an update on its programs.

UPDATE ON DRUG DEVELOPMENT PROGRAMS

Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; topical cationic peptide; prevention of catheter-related infections): A pivotal Phase III study being conducted by our development and commercialization partner Cadence Pharmaceuticals is in progress in the United States under a Special Protocol Assessment (SPA) agreement with the US FDA and in Europe. This confirmatory Phase III trial is a randomized, Evaluation Committee-blinded study to assess the effectiveness of Omigard(TM) vs. 10% povidone-iodine for the prevention of central venous catheter-related infections. This ongoing trial is known as the Central Line Infection Reduction Study, or CLIRS trial. Cadence expects they will complete enrollment of the 1,850 patients planned for the trial in the second quarter of 2008, with results available in the second half of 2008. If the results of the CLIRS trial are positive, Cadence expects to submit a New Drug Application ("NDA") for omiganan 1% gel in the first half of 2009.

Celgosivir (MX-3253; oral alpha-glucosidase I inhibitor; treatment of chronic hepatitis C virus infections): Final top-line results of a Phase II 12-week combination therapy study in non-responder and partial responder patients were announced April 11, 2007, demonstrating proof-of-concept and evidence of clinical benefit when adding celgosivir to the current standard-of-care HCV therapy (pegylated interferon plus ribavirin) as compared to the active control treatment (standard-of-care alone) in patients with chronic hepatitis C virus genotype 1 infections who were characterized as non-responders to prior therapy with optimized pegylated alpha interferon plus ribavirin.

In conjunct
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results

Post Your Comments:

(Date:6/18/2013)... HONG KONG, June 18, 2013 China Cord ... the "Company"), China,s leading provider of cord blood collection, ... storage services, today announced its preliminary unaudited financial results ... year 2013 ended March 31, 2013. ... for the fourth quarter of fiscal 2013 increased by ...

(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...

(Date:6/18/2013)... 2013 (PRWEB) June 18, 2013 ... system in North America, has introduced AccountLinx Plus, ... and payroll records between ExakTime’s software and industry-leading ... ExakTime software setup and keeps employee databases up-to-date ... from a business’ current payroll software, directly into ...

(Date:6/18/2013)... MD, USA (PRWEB) June 18, 2013 ... announced the opening of two new offices in Asia—one ... in Singapore will serve as RAPS’ Pan-Asia office ... office will be more focused on audiences within China. ... RAPS announced its partnership with five Singapore government agencies ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City [0] ExakTime Introduces AccountLinx Plus [0] RAPS Opens Offices in Singapore and China

... KOSN ) will announce its first quarter 2008 ... The announcement of Kosan,s first quarter 2008 financial ... webcast on May 1, 2008 at 1:30,p.m. Pacific / ... by dialing 888.680.0878 (US) or 617.213.4855 (international), access,code 63268386. ...

... SAN FRANCISCO, Calif., April 24 ,Exelixis, Inc. (Nasdaq: ... and chief executive officer of Exelixis, will present at ... ET/12:40,p.m. PT on Wednesday, April 30, 2008. Dr. Scangos ... strategy., The presentation will be webcast and may ...

... HOLX ), a diversified medical technologies company ... dedicated to,serving the healthcare needs of women, today ... operating results on Thursday, May 1, 2008 at,8:00 ... will host,a conference call on Thursday, May 1, ...

Cached Biology Technology:Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results 2 Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2

Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results Exelixis Announces April 30 Webcast of Presentation at the Morgan Stanley Global Healthcare Unplugged Conference Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens

(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...

(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...

(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...

Breaking Biology News(10 mins):Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... Disease Control and Prevention estimates that almost 18% of ... our growing obesity "epidemic" is driven by both inadequate ... extraordinarily difficult. One area that has caught the attention ... video game playing parallel obesity rates on a population ...

... the smoking ban in restaurants, bars and nightclubs, customers ... odors and the smell of old beer, that used ... looking at how the introduction of pleasant ambient scents ... According to Dr. Hendrik Schifferstein from Delft University of ...

... May 17, 2010 Country roadways can be hazardous for ... with moose, elk and caribou in North America and Europe ... the salt pools that collect following pavement deicing. ... with males weighing up to 720 kilograms, their salt cravings ...

Cached Biology News:Rigorous study confirms video game playing increases food intake in teens 2 Clubbers can smell a good nightspot 2 Of moose and men 2

Rigorous study confirms video game playing increases food intake in teens Clubbers can smell a good nightspot Of moose and men

Mouse Wnt-11 Affinity Purified Polyclonal Ab...

PEG 8000, Molecular Biology Grade...

Human VASA Biotinylated Affinity Purified PAb...

Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...

Biology Products:

Goat Anti-Mouse Wnt-11 Polyclonal Antibodies, from R&D Systems Polyethylene glycol 8000, Molecular Biology Grade from Research Organics, Inc.Goat Anti-Human VASA Polyclonal Antibody, Biotin Conjugated from R&D Systems Mouse Matrilin-4 from R&D Systems